| Literature DB >> 35420454 |
Bohdan L Bilyk1,2, Viralkumar V Panchal1,2, Mariana Tinajero-Trejo1,2, Jamie K Hobbs2,3, Simon J Foster1,2.
Abstract
The development of resistance to β-lactam antibiotics has made Staphylococcus aureus a clinical burden on a global scale. MRSA (methicillin-resistant S. aureus) is commonly known as a superbug. The ability of MRSA to proliferate in the presence of β-lactams is attributed to the acquisition of mecA, which encodes the alternative penicillin binding protein, PBP2A, which is insensitive to the antibiotics. Most MRSA isolates exhibit low-level β-lactam resistance, whereby additional genetic adjustments are required to develop high-level resistance. Although several genetic factors that potentiate or are required for high-level resistance have been identified, how these interact at the mechanistic level has remained elusive. Here, we discuss the development of resistance and assess the role of the associated components in tailoring physiology to accommodate incoming mecA.Entities:
Keywords: MRSA; MecA; Staphylococcus aureus; antimicrobial resistance
Mesh:
Substances:
Year: 2022 PMID: 35420454 PMCID: PMC9199415 DOI: 10.1128/mmbr.00159-21
Source DB: PubMed Journal: Microbiol Mol Biol Rev ISSN: 1092-2172 Impact factor: 13.044